Company intelligence / Profile preview

Firsthand Technology

Overview

Firsthand’s VR therapies have demonstrated significant reductions in patient-reported pain and opioid usage. In clinical settings:

Pancreatic cancer patients using COOL! and GLOW! reported 30% less pain, 20% less opioid use, with hospitals tracking reduced costs.
Chronic pain patients experienced a mean of 60% less pain during sessions and a total reduction of 33% after sessions compared to baseline.

The company continues to develop next-generation digital health solutions for physical and mental health applications.

Pear Therapeutics was mentioned as a potential partner to bring Firsthand’s VR experiences to wider use.

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Firsthand Technology.